Leadership
Dr. Frank R. Jones, President and Chief Executive Officer
Dr. Jones is a seasoned bio-tech entrepreneur. As the founder of Etubics, Dr. Jones has served as the Company’s Chairman of the Board of Director’s since its inception. He is the Principle Investigator on many of the company's National Institute of Health grants, which total over $7 million. From 1981 to 1996, Dr. Jones served as Founding Chairman and Chief Executive Officer of the publically traded medical device company IMRÉ CORPORATION (NASD: IMRE), which focused on immunoadsorption human treatments. From 1996 to 1998 Dr. Jones was Chairman and Chief Executive Officer of Scius Corporation, a private company. From 1998 to 2003 he consulted to the biotechnology industry and was the Managing Partner of Haidas Ranches, LLC a land development company. From 1983 until 1986, Dr. Jones was Director of the Immune Response Program of the Pacific Northwest Research Foundation in Seattle. Dr. Jones was a Researcher in the Department of Complement and Effector Biology at Memorial Sloan Kettering Cancer Center (“MSKCC”) in New York City from 1980 to 1981 and was a Research Associate in the Laboratory of Veterinary Oncology at MSKCC from 1981 to 1983. Dr. Jones holds a PhD degree from the University of Washington in Biological Structure/Cellular Immunology. He has 10 patents to his name and has published over 40 peer reviewed scientific papers.
Ms. Elizabeth S. Gabitzsch, Vice President, Research
Ms. Gabitzsch leads the products pre-clinical studies at Etubics. She is an expert in the area of vector transmission and has published scientific articles in that area of research as well as on the Company’s technology. She joins Etubics from the Centers for Disease Control and Prevention at Fort Collins, Colo. Previously she was employed at Colorado State University in the Arthropod Borne and Infectious Disease Laboratory (AIDL) collaborating in the area of virus vector transmission and immunology with Dr. Barry Beaty. The AIDL is internationally recognized for scientific progress in the area of mosquito disease transmission and bio-warfare agent research. Ms. Gabitzsch graduated from Colorado State University in Microbiology and Chemistry.
Ms. Carol R. Jones, Vice President of Administration and acting Chief Financial Officer
Ms. Jones was previously Vice President and Managing Partner of Haidas Ranches, LLC land development from 1996 to 2003. Ms. Jones has more than 20 years of administrative experience in various environments including seven years at the University of Washington working as a Budget Coordinator overseeing 16 grants and contracts with six figure annual budgets. She also has management experience from McDonnell Douglas Aircraft and Pacific Telephone and Telegraph in addition to having been involved in the administrative functions of two other startup companies including IMRE Corporation, of which was brought public. She graduated from Stevens Henager College, Salt Lake City, Utah.
Dr. Raj Dua, Vice President Operations
Dr. Dua is in charge of Operations at Etubics and directs Process Development, Manufacturing, Drug Supply Chain and Clinical Operations. Dr. Dua will become a full time employee following completing of major financing. Most recently, he was Vice President, Pharmaceutical Operations at Alder Bio-Pharmaceuticals where he oversaw all the process development, manufacturing and supply chain management functions for their monoclonal antibody based products. Dr. Dua has over 15 years of experience in development of cell based therapies, monoclonal antibodies and fusion proteins and extensive experience in the manufacturing field and regulatory submissions. Dr. Dua received his PhD at the University of Georgia and his MBA at the University of Washington. He has published several publications and patents.
Dr. Joseph P. Balint, Laboratory Director
Dr. Balint is a trained immunologist with 25 years experience in academic and corporate environments. He has taken products from the bench to the bedside, gaining FDA and ISO licensing. Dr. Balint is currently directing Etubics' laboratory operations and writing publications and patents. He also works at the bench doing ELISA, neutralization serology and cell-line operations. From 1982 to 1989 he was Director of Extracorporeal Products, IMRE CORPORATION; from 1989 to 1993 he was head of Product Development and from 1986 to 1996, he was head of the company's clinical diagnostic laboratory. Dr. Balint holds a PhD from Rutgers University (Microbiology). He has many patents to his name and has published over 40 scientific papers.
Ms. Kimberly R. Jones, Director of Corporate Development and Communications
Ms. Jones acts as the company's liaison for partners, including universities and pharmaceutical companies. Prior to Etubics, Ms. Jones was a senior account executive at Richmond Public Relations, working with companies ranging from entrepreneurial to publicly traded to increase their public image and reach sales goals. Ms. Jones graduated from the University of Washington with a degree in communications. She is a member of Junior League of Seattle and volunteers for the Puget Sound Affiliate of Susan G. Komen for the Cure's Race for the Cure.